創夢天地(01119.HK):進一步延長收購樂遊科技控股股份排他期
格隆匯3月12日丨創夢天地(01119.HK)宣佈於,於2020年3月12日,鬱國祥及樂遊與公司訂立了一份排他協議,內容有關公司就收購樂遊所有已發行股份可能作出的具先決條件自願有條件要約。
根據排他協議,公司已獲授予排他期,自排他協議日期起至(以較早者為準)(i)2020年4月15日(或根據排他協議延長的有關較後日期或各方可能書面協定的有關其他日期);或(ii)公司以書面形式通知鬱國祥與樂遊公司擬不再參與可能要約的日期。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.